Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Mar 14;41(1):79-83.
doi: 10.1055/s-0043-1778656. eCollection 2024 Feb.

Embolic Agents: Sclerotherapy

Affiliations
Review

Embolic Agents: Sclerotherapy

Christina Lim et al. Semin Intervent Radiol. .
No abstract available

PubMed Disclaimer

Similar articles

References

    1. Myers K. A history of injection treatments - II sclerotherapy. Phlebology. 2019;34(05):303–310. - PubMed
    1. Borecka-Sobczak J. Sclerotherapy - from historical research to the modern and efficient method of phlebological treatment. Phlebological Rev. 2021;29(01):1–6.
    1. Albanese G, Kondo K L. Pharmacology of sclerotherapy. Semin Intervent Radiol. 2010;27(04):391–399. - PMC - PubMed
    1. Mancini S, Lassueur F, Mariani F. Sclerosis of the great saphenous vein: an experimental study in humans of the sclerosing effect of an iodo-iodide solution and polidodecane (histology and electron microscopy) Phlébologie (Paris) 1991;44(02):461–468. - PubMed
    1. Urbanek T R, Piotr M, Jolanta A et al.Sclerotherapy contraindications, sequelaes, and complications - informing patients properly and objectively is required. Phlebological Rev. 2021;29:19–25.